Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Qiagen NV

Latest From Qiagen NV

Bio-Techne Makes Big Push Into Liquid Biopsy With Exosome Acquisition

Bio-Techne has reached an agreement to acquire Exosome Diagnostics, putting the firm in a stronger position in the emerging liquid biopsy and precision medicine spaces.

Companies Deals

Earnings Winners & Losers: IVD Big Hitters Roche, TMO, DHR, DGX, QGEN,

Medtech Insight highlights results from some of the leading IVD players. This week we spotlight Thermo Fisher Scientific, Danaher, Qiagen and Quest Diagnostics. But which among them are this season's earnings winners and losers?

Sales & Earnings Medical Device

Qiagen Buys STAT-Dx To Launch Next-Gen Syndromic Testing System

Qiagen has agreed to acquire STAT-Dx, a start-up that developed a multiplex diagnostic for common syndromes, for about $147m in upfront cash, and up to $44m in regulatory and commercial milestones.

Commercial Deals

Deals Shaping the Medical Industry, January 2018

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in December 2017.

Deals BioPharmaceutical
See All

Company Information